TOP STORIES

• ORGANIZATION No Clear Violation of Fair Competition Code in Diovan Case: Maker FTC Exec
  October 22, 2013

• BUSINESS Wholesalers’ Sluggish Price Settlement Rate Could Mar Reliability of Market Price Survey
  October 22, 2013

• ORGANIZATION JPMA Will Announce Response to Violation of PAL by Mitsubishi Tanabe in Near Future: Director General Goto
  October 21, 2013

• REGULATORY Ex-Health Minister Nagatsuma Eyes Unsworn Diet Testimony by Ex-Novartis Employee on Diovan Scandal
  October 18, 2013

• REGULATORY CSIMC Pricing Subcommittee OKs Indicator to Gauge Reasonableness of Premium’s Perpetuation
  October 17, 2013

• BUSINESS Gilead to Fully Enter Japan, File for Approval for Hepatitis C Treatment Sofosbuvir in 2014: President
  October 16, 2013

• BUSINESS Once-Weekly DPP-4 Inhibitors of MSD, Takeda to Bring New Dimension to Packed Market
  October 15, 2013

• BUSINESS Gilead to Enter Japan Full Force with Hepatitis C Treatment
  October 11, 2013

• REGULATORY CSIMC Pricing Subcommittee to Explore “Responses” to Diovan Uproar
  October 10, 2013

• ORGANIZATION Japan Self-Medication Industry Requests Health Minister to Remove JMA, JPA Members from OTC Drug Review Council
  October 9, 2013

• ORGANIZATION Blanket 14-Day Prescription Limit Should Be Scrapped: EFPIA Japan Chair
  October 8, 2013

• BUSINESS Quintiles Aims to Expand Business in Japan with More Employees: CEO
  October 8, 2013

• BUSINESS 3 Combination Drugs for Asthma, COPD Get Approval to Fuel Competition; NHI Price Listing Expected in November
  October 7, 2013

• ORGANIZATION Diovan Issue　is “Isolated Example,” Confidence in Japan Clinical Trials Not Lost: President Viehbacher of EFPIA
  October 7, 2013

• REGULATORY NIBIO to Strengthen Academia’s Drug Discovery Support Initiatives in Order to Evaluate 400 Research Themes by FY2015
  October 4, 2013

• ORGANIZATION JPMA Compliance Committee to Decide Penalties for Novartis for Diovan Case as Requested by Dr Teshirogi
  October 3, 2013

• BUSINESS Another Administrative Action Taken Against MTPC on Medway Injection; 3rd in 4 Years
  October 2, 2013

• REGULATORY Interim Report of Diovan Panel Fails to Lay Bare Who Altered Data, for What Purpose
  October 1, 2013

• BUSINESS Amgen Astellas BioPharma to Go on Stream Oct. 1; JV Chief Takahashi Eager to Make It a “Category Leader”
  September 30, 2013

• REGULATORY Japan Health Minister Meets Exec of Swiss Novartis, Seeks Cooperation in Diovan Probe
  September 27, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 207
• 208
• 209
• 210
• 211
• 212
• 213
• 214
• 215
• …
• Next ›
• 最終 »